GCTK
GlucoTrack, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · IL
$2.98
−10.24%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- +35.6%
- EBIT
- +56.0%
- EPS
- +19.6%
- Free cash flow
- -13.5%
- Operating cash flow
- -13.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +11.8%
- EBIT
- -10.6%
- Net income
- +14.2%
- EPS
- +64.5%
- Free cash flow
- -21.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026